ERYTECH Pharma S.A.
ERYTECH Pharma S.A. (ERYP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ERYP · as of Jun 9, 2026
Key Statistics
Explore ERYTECH Pharma S.A. Data
eryp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
eryp competitorsERYP
ALVR
BLUE
CERC
GRNA
KRONStock Performance
Full HistoryAbout ERYTECH Pharma S.A.
ERYTECH Pharma S.A. is a biopharmaceutical company specializing in the clinical development of red blood cell-based treatments for various cancers and orphan diseases. Its operations are based in Fran…
what is erytech pharma s.a. · eryp stock overview · erytech pharma s.a. company profile · who is erytech pharma s.a. ceo · eryp NASDAQ · erytech pharma s.a. headquarters · erytech pharma s.a. business segments
About Stock Overview & Key Data
ERYTECH Pharma S.A. (ERYP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 5, 2016. As of the latest trading session, ERYP stock price is $0.78, with a market capitalization of $47.4M. The stock has returned -23.53% over the past 12 months and +128.54% year-to-date.
According to 1 Wall Street analysts, the consensus rating for ERYTECH Pharma S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, ERYTECH Pharma S.A. reported revenue of — and net income of -$228000.00. For detailed data — including ERYTECH Pharma S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ERYTECH Pharma S.A. (ERYP) stock price is $0.78. The stock is traded on NASDAQ under the ticker symbol ERYP. The 52-week range is $0.30 – $1.47.